ArticleFrontiers in oncology2020
Survival Benefit and Genetic Profile of Pemetrexed as Initial Chemotherapy in Selected Chinese Patients With Advanced Lung Adenocarcinoma.
Abstract read
In one paragraph
Article in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Data mining-based identification of epigenetic signatures with discrimination potential of lung adenocarcinoma and squamous cell carcinoma.Molecular biology reports · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
50 authors.
Long-Hua GuoDepartment of Medical Oncology, Cancer Center, Meizhou People's Hospital (Huangtang Hospital), Meizhou Academy of Medical Sciences, Meizhou Hospital Affiliated to Sun Yat-Sen University, Meizhou, China.
Ming-Feng ZhangGuangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, China.
He-Long ZhangDepartment of Oncology, The Second Affiliated Hospital of Air Force Military Medical University, Xi'an, China.
Jian-Ying ZhouDepartment of Respiratory Disease, Thoracic Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Xiao-Hong CaiSichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Yu LongSichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Qi-Sen GuoInternal Medicine (Respiratory) of Oncology, Shandong Cancer Hospital Affiliated to Shandong University, Shangdong Academy of Medical Sciences, Shangdong Cancer Hospital and Institute, Jinan, China.
Nong YangLung Cancer and Gastrointestinal Unit, Department of Medical Oncology, Hunan Cancer Hospital/Affiliated Cancer Hospital of Xiangya School of Medicine, Changsha, China.
Jun ZhaoKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Thoracic Oncology, Peking University Cancer Hospital and Institute, Beijing, China.
Zhan-Hong XieRespiratory Medicine Department, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute for Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Bo JiangDepartment of Cadre Medical Oncology, No.3 Hospital Affiliated to Kunming Medical College (Yunnan Tumor Hospital), Kunming, China.
Ying ZhuDepartment of Cadre Medical Oncology, No.3 Hospital Affiliated to Kunming Medical College (Yunnan Tumor Hospital), Kunming, China.
Yun FanDepartment of Thoracic Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, China.
Cong-Ying XieDepartment of Radiation and Medical Oncology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Yi HuDepartment of Medical Oncology, Chinese PLA General Hospital, Beijing, China.
Yu YaoDepartment of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Jun JiaDepartment of Oncology, Dongguan People's Hospital, Dongguan, China.
Xiao-Ling LiDepartment of Thoracic Oncology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, China.
Jiu-Wei CuiCancer Center, The First Hospital of Jilin University, Changchun, China.
Xi-Zhao SuiDepartment of Thoracic Surgery, Peking University People's Hospital, Beijing, China.
Wen LinDepartment of Medical Oncology, Cancer Hospital of Shantou University Medical College, Shantou, China.
Ying ChengDepartment of Medical Oncology, Jilin Provincial Cancer Hospital, Changchun, China.
Hui-Juan WangDepartment of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital, Zhengzhou, China.
Chang-Li WangDepartment of Lung Cancer, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China.
Ming-Fang ZhaoDepartment of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.
Gui-Bin QiaoGuangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, China.
Li-Jun PengDepartment of Thoracic Surgery, General Hospital of Southern Theater Command, PLA, Guangzhou, China.
Lin YangDepartment of Thoracic Surgery, Shenzhen People's Hospital, 2nd Clinical Medical College of Jinan University, Shenzhen, China.
Gong-Yan ChenDepartment of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
Kai-Can CaiDepartment of Thoracic Surgery, Nanfang Hospital of Southern Medical University, Guangzhou, China.
Xin-Hua XuOncology Department, The First College of Clinical Medical Science, China Three Gorges University & Yichang Central People's Hospital, Yichang, China.
Liang-Ming ZhangDepartment of Medical Oncology, Yantai Yuhuangding Hospital, Yantai, China.
Guo-Sheng FengChemotherapy Section One, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
Jing-Min ZhouDepartment of Respiratory and Critical Care, Tianjin Chest Hospital, Tianjin, China.
Guo-Wu WuDepartment of Medical Oncology, Cancer Center, Meizhou People's Hospital (Huangtang Hospital), Meizhou Academy of Medical Sciences, Meizhou Hospital Affiliated to Sun Yat-Sen University, Meizhou, China.
Xiao-Rong DongCancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Li-Feng WangOncology Department, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
Hong-Mei ZhangDepartment of Clinical Oncology, Xijing Hospital, The Fourth Military Medical University, Xi'an, China.
Ya-Jie GaoDepartment of Oncology, The First Affiliated Hospital of Dalian Medical University, Dalian, China.
Qiu-Ying JiangDepartment of Oncology, The Second Hospital Affiliated to Harbin Medical University, Harbin, China.
Shun-Dong CangDepartment of Oncology, Henan Provincial People's Hospital, Zhengzhou, China.
Zhi-Xiong YangDepartment of Pulmonary Oncology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Xia SongDepartment of Respiratory Medicine, Shanxi Provincial Cancer Hospital, Taiyuan, China.
Xiao-Qing LiuDepartment of Pulmonary Oncology, The Fifth Medical Centre, Chinese PLA General Hospital, Beijing, China.
Bo ZhuInstitute of Cancer, Xinqiao Hospital, The Third Military Medical University, Chongqing, China.
Feng-Xia ChenThoracic Surgery, Hainan General Hospital, Haikou, China.
Chun-Hong HuCancer Center, The Second Xiangya Hospital, Central South University, Changsha, China.
Xi ChenDepartment of Oncology, The 900th Hospital of the People's Liberation Army Joint Service Support Force, Fuzong Clinical Medical College of Fujian Medical University, Fuzhou, China.
Yi-Long WuGuangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, China.
Qing ZhouGuangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, China.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
chemotherapyChineselung adenocarcinomanext-generation sequencingpemetrexed
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.